In the original article, there was an error. In the Abstract there was a mistake in the statement of the results of the pooled prevalence of congenital myopathy in the all-age population. Instead of āThe pooled prevalence of congenital myopathy in the all-age population was 1.50 (95% CI, 0.93ā2.06) per 100,000, while the prevalence in the child population was 2.73 (95% CI, 1.34ā4.12) per 100,000ā, it should be āThe pooled prevalence of congenital myopathy in the all-age population was 1.62 (95% CI, 1.13ā2.11) per 100,000, while the prevalence in the child population was 2.76 (95% CI, 1.34ā4.18) per 100,000.ā
A correction has been made to Abstract, Results, Paragraph 1:
Results: A total of 11 studies were included in the systematic review and meta-analysis. Of the 11 studies included, 10 (90.9%) were considered medium-quality, one (9.1%) was considered low-quality, and no study was assessed as having a high overall quality. The pooled prevalence of congenital myopathy in the all-age population was 1.62 (95% CI, 1.13ā2.11) per 100,000, while the prevalence in the child population was 2.76 (95% CI, 1.34ā4.18) per 100,000. In the pediatric population, the prevalence among males was 2.92 (95% CI, ā1.70 to 7.55) per 100,000, while the prevalence among females was 2.47 (95% CI, ā1.67 to 6.61) per 100,000. The prevalence estimates of the all-age population per 100,000 were 0.20 (95% CI 0.10ā0.35) for nemaline myopathy, 0.37 (95% CI 0.21ā0.53) for core myopathy, 0.08 (95% CI ā0.01 to 0.18) for centronuclear myopathy, 0.23 (95% CI 0.04ā0.42) for congenital fiber-type disproportion myopathy, and 0.34 (95% CI, 0.24ā0.44) for unspecified congenital myopathies. In addition, the prevalence estimates of the pediatric population per 100,000 were 0.22 (95% CI 0.03ā0.40) for nemaline myopathy, 0.46 (95% CI 0.03ā0.90) for core myopathy, 0.44 (95% CI 0.03ā0.84) for centronuclear myopathy, 0.25 (95% CI ā0.05 to 0.54) for congenital fiber-type disproportion myopathy, and 2.63 (95% CI 1.64ā3.62) for unspecified congenital myopathies.
In the original article, there was a mistake in Table 1 as published. The number of cases in the reference Norwood et al. should be 41, not 18. The corrected Table 1 appears below.
Table 1
| References | Country/region | Age (years) | Data source | Diagnostic criteria | Prevalence date | Population size | Number of cases | Prevalence per 100,000 (95% CI) | Overall scored |
|---|---|---|---|---|---|---|---|---|---|
| Amburgey et al. (21) | United States (Michigan) | <18 | Hospital/clinic chart review, administrative database | Clinical history with at least 1 additional supporting study (biopsy, genetic testing, or first-degree relative) | 2010 | 1,211,100 | 46 | 3.80 (2.93, 4.66) | Medium |
| Chung et al. (22) | Southern China (Hong Kong) | <19 | Hospital/clinic chart review, administrative database | European Neuromuscular Center (23), World Federation of Neurology Research Committee (24)a | 2001.06.30 | 1,335,469 | 45 | 3.22 (2.43, 4.01) | Medium |
| Darin and Tulinius (25) | Western Sweden | <16 | Mailed survey, hospital/clinic chart review, administrative databases | Muscle and Nerve (26)b | 1995.01.01 | 359,676 | 18 | 5.01 (3.37, 6.64) | Medium |
| Hughes et al. (27) | Northern Ireland | All | Hospital/clinic chart review, administrative database, relatives. | European Neuromuscular Center (23), World Federation of Neurology Research Committee (24)a | 1994.06.30 | 1,573,282 | 57 | 3.62 (2.87, 4.37) | Medium |
| Lefter et al. (28) | Ireland | >18 | Hospital/clinic chart review, administrative database | Table e-1 at Neurology.org (28) | 2013.12.31 | 3,439,565 | 33 | 0.96 (0.65, 1.27) | Medium |
| Norwood et al. (29) | Northern England | All | Hospital/clinic chart review, administrative database | European Neuromuscular Center (23), Monogenic neuromuscular disorders (30)c | 2007.08.01 | 2,990,000 | 41 | 0.60 (0.33, 0.87) | Medium |
| Pagola-Lorz et al. (31) | Northern Spain (Navarre) | All | Hospital/clinic chart review, administrative database | Monogenic neuromuscular disorders (32), undiagnosed genetic muscle disease (33)c | 2016 | 640,647 | 8 | 1.25 (0.44, 2.06) | Medium |
| Santos et al. (34) | Portugal | <15 | NM | Details are not available | 2001 | 1,656,602 | 27 | 1.63 (1.07, 2.19) | Low |
| Tangsrud and Halvorsen (35) | Southern Norway | <18 | Mailed survey, hospital/clinic chart review | System proposed by Dubowitz (36)b | 1983.01.01 | 573,762 | 3 | 0.52 (ā0.05, 1.10) | Medium |
| Theadom et al. (37) | New Zealand | All | Hospital/clinic chart review, administrative database | Details are not available | 2014.04.01 | 4,242,048 | 60 | 1.41 (1.08, 1.75) | Medium |
| Witting et al. (38) | Denmark | >5 | Mailed survey, hospital/clinic chart review, administrative database | Highly dependent on histological findings | NM | 5,400,000 | 82 | 1.52 (1.22, 1.82) | Medium |
Characteristics of the included studies on congenital myopathy prevalence.
CI, confidence interval; NM, not mentioned.
Diagnosis based on characteristic histochemical abnormalities.
Highly dependent on histological findings.
Genetic confirmation or clinical phenotype + characteristic histological findings.
Quality of study reporting assessment; details are shown in Supplementary Material 2.
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
21.
AmburgeyKMcnamaraNBennettLRMccormickMEAcsadiGDowlingJJ. Prevalence of congenital myopathies in a representative pediatric united states population. Ann Neurol. (2011) 70:662ā5. 10.1002/ana.22510
22.
ChungBWongVIpP. Prevalence of neuromuscular diseases in Chinese children: a study in southern China. J Child Neurol. (2003) 18:217ā9. 10.1177/08830738030180030201
23.
DubowitzV. Diagnostic criteria for neuromuscular disorders: Edited by Alan E. H. Emery. Published 1994, European Neuromuscular Centre, Baarn, The Netherlands. ISBN 90 261 0719 6, 72 pp. Neuromuscular Disord. (1994) 4:292ā3. 10.1016/0960-8966(94)90038-8
24.
World Federation of Neurology Research Committee Research Group on Neuromuscular Diseases. J Neurol Sci. (1988) 86, 333ā360.
25.
DarinNTuliniusM. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord. (2000) 10:1ā9. 10.1016/S0960-8966(99)00055-3
26.
BrookeMHCarrollJERingelSP. Congenital hypotonia revisited. Muscle Nerve. (1979) 2:84ā100. 10.1002/mus.880020203
27.
HughesMIHicksEMNevinNCPattersonVH. The prevalence of inherited neuromuscular disease in Northern Ireland. Neuromuscul Disord. (1996) 6:69ā73. 10.1016/0960-8966(94)00017-4
28.
LefterSHardimanORyanAM. A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland. Neurology. (2017) 88:304ā13. 10.1212/WNL.0000000000003504
29.
NorwoodFLHarlingCChinneryPFEagleMBushbyKStraubV. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. (2009) 132:3175ā86. 10.1093/brain/awp236
30.
KaplanJC. Gene table of monogenic neuromuscular disorders (nuclear genome only) Vol 19. No 1 January 2009. Neuromuscul Disord. (2009) 19:77ā98. 10.1016/j.nmd.2008.11.001
31.
Pagola-LorzIVicenteEIbanezBTorneLElizalde-BeirasIGarcia-SolaesaVet al. Epidemiological study and genetic characterization of inherited muscle diseases in a northern Spanish region. Orphanet J Rare Dis. (2019) 14:276. 10.1186/s13023-019-1227-x
32.
BonneGRivierFHamrounD. The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome). Neuromuscul Disord. (2017) 27:1152ā83. 10.1016/j.nmd.2017.10.005
33.
HarrisELavalSHudsonJBarresiRDe WaeleLStraubVet al. Undiagnosed genetic muscle disease in the north of England: an in depth phenotype analysis. PLoS Curr. (2013) 5:ecurrents.md.37f840ca67f5e722945ecf755f40487e. 10.1371/currents.md.37f840ca67f5e722945ecf755f40487e
34.
SantosMAFinezaIMorenoTCabralPFerreiraJCSilvaRLet al. G.P.7 07 Epidemiology of neuromuscular disorders in Portugal at pediatric age. Neuromuscular Disord. (2006) 16:703. 10.1016/j.nmd.2006.05.192
35.
TangsrudSEHalvorsenS. Child neuromuscular disease in southern Norway. Prevalence, age and distribution of diagnosis with special reference to ānon-Duchenne muscular dystrophyā. Clin Genet. (1988) 34:145ā52. 10.1111/j.1399-0004.1988.tb02854.x
36.
DubowitzV. Muscle disorders in childhood. Major Probl Clin Pediatr. (1978) 16:iiiāxiii, 1ā282.
37.
TheadomARodriguesMPokeGO'gradyGLoveDHammond-TookeGet al. A Nationwide, population-based prevalence study of genetic muscle disorders. Neuroepidemiology. (2019) 52:128ā35. 10.1159/000494115
38.
WittingNWerlauffUDunoMVissingJ. Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark. Neurol Genet. (2017) 3:e140. 10.1212/NXG.0000000000000140
Summary
Keywords
prevalence, congenital myopathy, nemaline myopathy, core myopathy, centronuclear myopathy, congenital fiber-type disproportion myopathy
Citation
Huang K, Bi F-F and Yang H (2022) Corrigendum: A Systematic Review and Meta-Analysis of the Prevalence of Congenital Myopathy. Front. Neurol. 13:857959. doi: 10.3389/fneur.2022.857959
Received
19 January 2022
Accepted
19 January 2022
Published
14 February 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
Ā© 2022 Huang, Bi and Yang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Fang-Fang Bi fangfangbi@csu.edu.cnHuan Yang yangh69@126.com
This article was submitted to Neuroepidemiology, a section of the journal Frontiers in Neurology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.